INS and obesity due to melanocortin 4 receptor deficiency: It can reduce plasma glucose levels by enhancing insulin sensitivity, which benefits patients with a variety of insulin-resistant states, including impaired glucose tolerance, polycystic ovary syndrome, obesity, and metabolic syndrome [1, 2].